Erythromycin Breath Test (ERMBT)

PROCEDURE2 trials

Sponsors

University of Michigan Rogel Cancer Center

Conditions

HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer

Phase 2

UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer

CompletedNCT00146042

University of Michigan Rogel Cancer CenterHER-2 Positive Metastatic Breast Cancer

Start: 1999-03-31End: 2005-03-31Updated: 2012-10-05

Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer

CompletedNCT00148070

University of Michigan Rogel Cancer CenterMetastatic Breast Cancer

Start: 1999-03-31End: 2006-02-28Updated: 2012-10-05